Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stabilitySjoerd H. van der Burg, C J Melief, W. Martin Kast et al.|The Journal of Immunology|1996Cited by 396
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I–II trialWillemien J. van Driel, J. Baptist Trimbos, Gert Jan Fleuren et al.|European Journal of Cancer|1999Cited by 230
Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells.Hans W. Nijman, C J Melief, Monique J. Kleijmeer et al.|The Journal of Experimental Medicine|1995Cited by 184
CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells.Marjan J.W. Visseren, C J Melief, A van Elsas et al.|The Journal of Immunology|1995Cited by 123
An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cellsSjoerd H. van der Burg, W. Martin Kast, Elisabeth Ras et al.|Human Immunology|1995Cited by 90